United Therapeutics Corporation Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
United Therapeutics Corporation (UTHR) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 100.00 thousand shares for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-26.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2020-02-26
- United Therapeutics Corporation incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-03-31 was 300.00K shares, a 87.50% decline year-over-year.
- United Therapeutics Corporation incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2016-09-30 was 2.30M shares, a 23.33% decline year-over-year.
- United Therapeutics Corporation incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2016-06-30 was 2.10M shares, a 36.36% decline year-over-year.
- United Therapeutics Corporation incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2016-03-31 was 2.40M shares.
- United Therapeutics Corporation incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2017 was 100.00K shares, a 95.65% decline from fiscal 2016.
- United Therapeutics Corporation incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2016 was 2.30M shares, a 23.33% decline from fiscal 2015.
- United Therapeutics Corporation incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2015 was 3.00M shares, a 57.89% increase from fiscal 2014.
- United Therapeutics Corporation incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2014 was 1.90M shares, a 588.41% increase from fiscal 2013.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | 100.00K shares 10-K · filed 2020-02-26 | |||||||
| 2017-09-30 | 100.00K shares 10-Q · filed 2018-10-31 | |||||||
| 2017-06-30 | 100.00K shares 10-Q · filed 2018-08-01 | |||||||
| 2017-03-31 | 300.00K shares 10-Q · filed 2018-05-02 | |||||||
| 2016-12-31 | 2.30M shares 10-K · filed 2019-02-27 | |||||||
| 2016-09-30 | 2.30M shares 10-Q · filed 2017-10-25 | 2.30M shares 10-Q · filed 2017-10-25 | ||||||
| 2016-06-30 | 2.10M shares 10-Q · filed 2017-07-27 | 2.30M shares 10-Q · filed 2017-07-27 | ||||||
| 2016-03-31 | 2.40M shares 10-Q · filed 2017-04-26 | |||||||
| 2015-12-31 | 3.00M shares 10-K · filed 2018-02-21 | 3.01M shares 10-K · filed 2016-02-25 | ||||||
| 2015-09-30 | 3.00M shares 10-Q · filed 2016-10-27 | 3.03M shares 10-Q · filed 2015-10-27 | 3.10M shares 10-Q · filed 2016-10-27 | 3.08M shares 10-Q · filed 2015-10-27 | ||||
| 2015-06-30 | 3.30M shares 10-Q · filed 2016-07-28 | 3.27M shares 10-Q · filed 2015-07-28 | 3.10M shares 10-Q · filed 2016-07-28 | 3.10M shares 10-Q · filed 2015-07-28 | ||||
| 2014-12-31 | 1.90M shares 10-K · filed 2017-02-22 | 1.91M shares 10-K · filed 2015-02-24 | ||||||
| 2014-09-30 | 1.72M shares 10-Q · filed 2015-10-27 | |||||||
| 2014-06-30 | 1.56M shares 10-Q · filed 2015-07-28 | 1.67M shares 10-Q · filed 2015-07-28 | ||||||
| 2014-03-31 | 1.78M shares 10-Q · filed 2015-04-28 | |||||||
| 2013-12-31 | 276.00K shares 10-K · filed 2016-02-25 | |||||||
| 2013-09-30 | 397.00K shares 10-Q · filed 2014-10-28 | |||||||
| 2011-12-31 | 263.00K shares 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |